Exercise capacity · people with pulmonary hypertension
2 findings from 1 review
Exercise capacity: peak power watts · people with pulmonary hypertension
1 finding from 1 review
Training intensity: fInal training session (% baseline peak work capacity) · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Serious adverse events · people with pulmonary hypertension
Exercise showed no clear difference in serious adverse events compared with control (moderate certainty).
1 finding from 1 review
HRQoL SF‐36: PCS units · people with pulmonary hypertension
1 finding from 1 review
HRQoL SF‐36: MCS units · people with pulmonary hypertension
1 finding from 1 review
Cardiopulmonary haemodynamics (mPAP) mmHg · people with pulmonary hypertension
1 finding from 1 review
Time in moderate‐intensity physical activity · people with COPD, clinical stability
1 finding from 1 review
Intervention not reported
Peak exercise capacity: Power (W) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Peak exercise capacity: Peak oxygen consumption (VO2peak) (L/min) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Peak exercise test: Lactate threshold (L/min) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Peak exercise test: Isowork minute ventilation (VE) (L) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Peak exercise test: Isowork dyspnoea score · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Exercise tolerance: Endurance time (min) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Functional exercise capacity: Six‐minute walk distance (m) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Change in Exercise Capacity (6MWD) · Adults (>18 years) with pulmonary hypertension of varied aetiology (PAH, CTEPH and left heart disease)
1 finding from 1 review
Intervention not reported
Exercise capacity · patients with pulmonary hypertension secondary to systemic scleroderma.
1 finding from 1 review
no estimate extracted
67 participants
Very low
Dyspnoea during exercise Modified Borg dyspnoea score at end of 6‐minute walk test Scores range from 0 to 10, with lower scores indicating less shortness of breath · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Health‐related Quality of Life: Dyspnoea domain of the CRQ · people with chronic obstructive pulmonary disease
1 finding from 1 review